中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

吲哚菁绿清除试验及肝脏有效血流量评估慢性肝炎患者肝脏储备功能的意义

秦华 王文政 王占兰

戴文聪, 臧梦雅, 袁国盛, 等. 肝动脉灌注化疗及其综合治疗方案对中晚期肝细胞癌患者的临床疗效及预后因素分析[J]. 临床肝胆病杂志, 2023, 39(7): 1592-1599. DOI: 10.3969/j.issn.1001-5256.2023.07.013.
引用本文: 戴文聪, 臧梦雅, 袁国盛, 等. 肝动脉灌注化疗及其综合治疗方案对中晚期肝细胞癌患者的临床疗效及预后因素分析[J]. 临床肝胆病杂志, 2023, 39(7): 1592-1599. DOI: 10.3969/j.issn.1001-5256.2023.07.013.
DAI WC, ZANG MY, YUAN GS, et al. Efficacy of hepatic arterial infusion chemotherapy and its multimodality therapeutic regimens in treatment of patients with advanced hepatocellular carcinoma and related prognostic factors[J]. J Clin Hepatol, 2023, 39(7): 1592-1599. DOI: 10.3969/j.issn.1001-5256.2023.07.013.
Citation: DAI WC, ZANG MY, YUAN GS, et al. Efficacy of hepatic arterial infusion chemotherapy and its multimodality therapeutic regimens in treatment of patients with advanced hepatocellular carcinoma and related prognostic factors[J]. J Clin Hepatol, 2023, 39(7): 1592-1599. DOI: 10.3969/j.issn.1001-5256.2023.07.013.

吲哚菁绿清除试验及肝脏有效血流量评估慢性肝炎患者肝脏储备功能的意义

DOI: 10.3969/j.issn.1001-5256.2014.02.011
详细信息
  • 中图分类号: R575.2

Significance of ICGR15 and EHBF in evaluating liver reserve function among patients with chronic hepatitis

  • 摘要:

    目的探讨吲哚菁绿清除试验15 min滞留(ICGR15)、肝脏有效血流量(EHBF)评估慢性肝炎患者肝脏储备功能的临床价值。方法对82例慢性肝炎患者在治疗前行ICG清除试验和EHBF测定,同时检测患者ALT、TBil、Alb、PTA、CHE等指标。分别观察轻、中、重度患者;ALT正常与异常组患者;TBil正常与异常组患者的ICGR15、EHBF两项指标变化。对患者的ICGR15、EHBF进行受试者工作特征曲线分析,探讨ICG清除试验及EHBF对病情预测的价值。计量资料数据以中位数±四分位数间距表示,多组间比较采用Kruskal-Wallis H检验;两组间比较采用Mann-Whitney U检验。结果 (1)在轻度与重度、中度与重度患者间ICGR15、EHBF差异均有统计学意义(H值分别为5.0、12.0、25.0、29.0,P<0.05)。(2)在ALT正常与异常组间,ICGR15、EHBF的差异无统计学意义(U值为135.5、146.0,P值为0.089、0.155)。(3)在TBil正常与异常组间,ICGR15、EHBF的差异均有统计学意义(U值为68.0、84.0,P&l...

     

  • [1]LI GM.Correlation analysis of liver function reserve and hepatic fibrosis in patients with chronic liver disease[J].China Med Herald, 2012, 9 (13) :181-182. (in Chinese) 李广明.慢性肝病肝脏储备功能与肝纤维化的相关性分析[J].中国医药导报, 2012, 9 (13) :181-182.
    [2]LI BL, MU Y, JIANG L, et al.Evaluation on hepatic reserve function of patients with hepatocellular carcinoma after partial hepatectomy by Child-Pugh classification with Fibroscan and ICG measurement[J].Chin J Liver Dis:Electron Vers, 2013, 5 (3) :5-8. (in Chinese) 李宝亮, 穆毅, 蒋力, 等.Child-Pugh分级联合ICG与肝瞬时弹性值评估肝部分切除术肝细胞癌患者肝储备功能[J].中国肝脏病杂志:电子版, 2013, 5 (3) :5-8.
    [3]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Hepatol, 2000, 8 (6) :324-329. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
    [4]HASHIMOTO M, WATANABE G.Hepatic parenchymal cell volume and the indocyanine green tolerance test[J].J Surg Res, 2000, 92 (2) :222-227.
    [5]MATSUI Y, TU W, KITDAE H, et al.Hepatocyte volume as an indicator of hepatic functional reserve in cirrhotic patients with live tumours[J].J Gastroenterol Hepatol, 1996, 11 (3) :540-548.
    [6]SCHEINGRABER S, RICHTER S, IGNA D, et al.Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy[J].Clin Transplant, 2007, 21 (6) :689-695.
    [7] DONG JH, ZHENG SS, CHEN XP, et al.Consensus on evaluation of hepatic functional reserve before hepatectomy (2011 edition) [J].Chin J Digest Surg, 2011, 10 (1) :20-25. (in Chinese) 董家鸿, 郑树森, 陈孝平, 等.肝切除术前肝脏储备功能评估的专家共识 (2011版) [J].中华消化外科杂志, 2011, 10 (1) :20-25.
    [8]LI JF, HU YQ, HE SQ.Research progress in evaluation of liver reserve function[J].China Med Herald, 2013, 10 (24) :41-44. (in Chinese) 李江发, 胡虞乾, 何松青.肝脏储备功能评估的研究进展[J].中国医药导报, 2013, 10 (24) :41-44.
    [9]YUAN JL, DING YM, WANG B.Clinical value of ICGR15for assessing hepatic resering function in liver cirrhosis patients after pericardil devascularization[J].J Clin Hepatol, 2012, 28 (9) :671-673. (in Chinese) 袁吉林, 丁佑铭, 汪斌.ICGR15在肝硬化断流术前评估肝脏储备功能的应用价值[J].临床肝胆病杂志, 2012, 28 (9) :671-673.
    [10]YOSHITAKA I, MANABU M, EIJI M, et al.Clinical applications of ICG Finger Monitor in patients with liver disease[J].Hepatology, 1993, 19 (2) :232-240.
    [11]FAYBIK P, HETZ.PLASMA H.Disappearance Rate of Indocyanine Green in Liver Dysfunction[J].Transplantation Proceedings, 2006, 38 (3) :801-802.
    [12]HU SL, HU AR, JIANG SW, et al.Evaluation of indocyanine green clearance test for estimation of prognosis in patients with liver failure[J].Chin Prev Med, 2012, 13 (6) :443-446. (in Chinese) 胡守廉, 胡爱荣, 蒋素文, 等.脉冲式色素浓度分析法吲哚菁绿清除试验在肝衰竭患者预后判断中的价值[J].中国预防医学杂志, 2012, 13 (6) :443-446. (in Chinese)
    [13]MA CH, CHEN Y, CHEN CW, et al.Prognostic value of indocyanine green and liver reserve function in acute and acute-on-chronic liver failure patients[J].J Clin Hepatol, 2012, 28 (5) :372-375. (in Chinese) 马春华, 陈煜, 陈成伟, 等.吲哚菁绿清除试验对急性/慢加急性肝衰竭患者预后的评价[J].临床肝胆病杂志, 2012, 28 (5) :372-375.
    [14] HASHIMOTO M, WATANABE G.Hepatic parenchymal cell volume and the indocyanine green tolerance test[J].J Surg Res, 2000, 92 (2) :222-227.
    [15]LI K, FENG XB, LIN H, et al.Clinical significance of pulse dye densitometry in effective hepatic blood flow detection[J].J Third Milit Med Univ, 2009, 31 (23) :2358-2360. (in Chinese) 李昆, 冯晓彬, 林恒, 等.脉动色素浓度测定法检测有效肝脏血流量对肝病患者的临床意义[J].第三军医大学学报, 2009, 31 (23) :2358-2360.
  • 期刊类型引用(5)

    1. 康志龙,周益民,宋燕州,张昆,苏一男,魏文平,赵新,李志伟. 靶向免疫治疗联合经肝动脉灌注化疗治疗不可切除肝细胞癌的临床效果及转化治疗的影响因素. 中国医学创新. 2025(01): 47-51 . 百度学术
    2. 许海明,胡永奎,梁平,钟腾猛,陆炳站. 中晚期肝癌患者经动脉化疗栓塞治疗后短期效果及长期预后的影响因素分析. 大医生. 2025(06): 27-31 . 百度学术
    3. 彭林辉,陈涛,徐云修修,王捷,陈捷,李永,黄拼搏,钟国平,陈茜,叶聪婷,陈亚进. mFOLFOX7方案全身化疗联合卡瑞利珠单克隆抗体和阿帕替尼治疗肝细胞癌合并Vp4型门静脉癌栓的疗效. 中华消化外科杂志. 2024(02): 265-271 . 百度学术
    4. 李洁,李瑞娟,鲁志兵,曾筱怡. 肝动脉灌注化疗联合程序性死亡受体1抗体及仑伐替尼治疗晚期肝癌合并门静脉癌栓的效果. 中国当代医药. 2024(26): 43-46+51 . 百度学术
    5. 黄乾鑫,神斌,肖晋昌,高志康,吕墩涛,李艳,徐浩,张庆桥. 载药微球经导管动脉化疗栓塞术联合肠系膜上动脉灌注化疗治疗肝细胞癌合并门静脉癌栓的效果分析. 临床肝胆病杂志. 2024(12): 2457-2463 . 本站查看

    其他类型引用(0)

  • 加载中
计量
  • 文章访问数:  595
  • HTML全文浏览量:  31
  • PDF下载量:  245
  • 被引次数: 5
出版历程
  • 出版日期:  2014-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回